NCT00483821 A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC Status COMPLETED Phase N/A
NCT00483639 Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer Status COMPLETED Phase N/A
NCT00482872 Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer Status COMPLETED Phase N/A
NCT00468169 Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00466856 Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors Status TERMINATED Phase PHASE2
NCT00465725 A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00462735 Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00453336 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract Status COMPLETED Phase PHASE2
NCT00448552 Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00448240 Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT00446446 PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) Status COMPLETED Phase PHASE2
NCT00442520 Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy Status COMPLETED Phase N/A
NCT00437372 Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients Status COMPLETED Phase PHASE1
NCT00431925 Can Cytokines Predict the Severity of Acute Mucositis and the Need for Gastrostomy Tubes (PEG)? Status UNKNOWN Phase N/A
NCT00427102 MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck Status TERMINATED Phase PHASE1
NCT00425750 Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00423930 Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE2